Sommario

• • ·Editorial board

    Pagina :i

    

• Editorial

  • ·Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic

    Pagina :317-318

    Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard

    Mappa Mappa

• Reviews

  • ·Drugs acting on renin angiotensin system and use in ill patients with COVID-19

    Pagina :319-325

    Joachim Alexandre, Jean-Luc Cracowski, Vincent Richard, Béatrice Bouhanick, French Society of Pharmacology and Therapeutics (SFPT)

    Riassunto Riassunto Mappa Mappa  
  • ·Diabetes and COVID-19

    Pagina :327-333

    Béatrice Bouhanick, Jean-Luc Cracowski, Jean-Luc Faillie, the French Society of Pharmacology, Therapeutics (SFPT)

    Riassunto Riassunto Mappa Mappa
  • ·Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review

    Pagina :335-342

    Lucile Grange, Philippe Guilpain, Marie-Elise Truchetet, Jean-Luc Cracowski, French Society of Pharmacology and Therapeutics

    Riassunto Riassunto Mappa Mappa
  • ·Addictovigilance contribution during COVID-19 epidemic and lockdown in France

    Pagina :343-354

    Maryse Lapeyre-Mestre, Alexandra Boucher, Amélie Daveluy, Valérie Gibaja, Emilie Jouanjus, Michel Mallaret, Helene Peyrière, Joëlle Micallef, French Addictovigilance Network, Emilie Bouquet, Leila Chaouachi, Cécile Chevallier, Sylvie Deheul, Céline Eiden, Nathalie Fouilhé, Chistine Fournier-Choma, Elisabeth Frauger, Marylène Guerlais, Reynald Le Boisselier, Ghada Miremont, Anne Roussin, Juliana Tournebize

    Riassunto Riassunto Mappa Mappa  
  • ·Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection

    Pagina :355-362

    Joëlle Micallef, Thomas Soeiro, Annie-Pierre Jonville-Béra, French Society of Pharmacology, Therapeutics (SFPT)

    Riassunto Riassunto Mappa Mappa  
  • ·Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence

    Pagina :363-370

    M. Roustit, R. Guilhaumou, M. Molimard, M.-D. Drici, S. Laporte, J.-L. Montastruc, French Society of Pharmacology and Therapeutics (SFPT)

    Riassunto Riassunto Mappa Mappa
  • ·“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers

    Pagina :371-379

    Alexandre Gérard, Serena Romani, Audrey Fresse, Delphine Viard, Nadège Parassol, Aurélie Granvuillemin, Laurent Chouchana, Fanny Rocher, Milou-Daniel Drici, French Network of Pharmacovigilance Centers

    Riassunto Riassunto Mappa Mappa  

• Letters to the editor

  • ·Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France

    Pagina :381-384

    François Montastruc, Charles Romano, Jean-Louis Montastruc, Stein Silva, Thierry Seguin, Vincent Minville, Bernard Georges, Béatrice Riu-Poulenc, Olivier Fourcade

    Mappa Mappa
  • ·Chloroquine and hydroxychloroquine during pregnancy: What do we know?

    Pagina :384-385

    Isabelle Lacroix, Justine Bénévent, Christine Damase-Michel

    Mappa Mappa
  • ·Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data

    Pagina :385-387

    Aurélie Grandvuillemin, Audrey Fresse, Clément Cholle, Samir Yamani, Anne Dautriche, French Network of Regional Pharmacovigilance Centres

    Mappa Mappa
  • ·NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection

    Pagina :387-388

    Medine Cumhur Cure, Adem Kucuk, Erkan Cure

    Mappa Mappa

• Postface

  • ·Is the drug a scientific, social or political object?

    Pagina :389-391

    Régis Bordet

    Mappa Mappa